Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2005
09/01/2005US20050191689 Novel nucleic acid base pair
09/01/2005US20050191679 Schizochytrium fatty acid synthase (FAS) and products and methods related thereto
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders
09/01/2005US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders
09/01/2005US20050191639 Method to isolate genes involved in aging
09/01/2005US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics
09/01/2005US20050191318 Recombinant bacterial host; vector encoding egg or sperm species specific polypeptide; inducing sterility; baits for controlling animal and rodent populations
09/01/2005US20050191287 Bioinsecticide formulation consisting of Bacillus thuringiensis var israelensis, and its concerning manufacture proceedings
09/01/2005US20050191279 Biologic-chemical fungicide compositions and methods of use
09/01/2005US20050188705 Assembly and method for cryo-preservation of specimens in a cryogen-free environment
09/01/2005CA2788707A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
09/01/2005CA2567042A1 Enrichment methods for the detection of pathogens and other microbes
09/01/2005CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
09/01/2005CA2557496A1 Frozen lactic acid bacteria culture of individual pellets
09/01/2005CA2556913A1 Solid-fluid composition and uses thereof
09/01/2005CA2556418A1 Methods and materials using signaling probes
09/01/2005CA2556271A1 Use of indanoyl amide to stimulate secondary metabolism in taxus sp.
09/01/2005CA2556172A1 Selective growth medium for listeria spp
09/01/2005CA2555972A1 Hyphal growth in fungi
09/01/2005CA2555737A1 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
09/01/2005CA2555377A1 Genetic analysis by sequence-specific sorting
08/2005
08/31/2005EP1568778A1 Hydantoinase from agrobacterium
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568776A2 DNA coding for mutant isopropylmalate synthase, l-leucine-producing microorganism and method for producing l-leucine
08/31/2005EP1568775A1 Cancer-associated gene
08/31/2005EP1568774A2 Recombinant production of novel polyketides
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568768A1 PROTEIN BINDING TO Akt2
08/31/2005EP1567863A2 Methods of therapy and diagnosis
08/31/2005EP1567660A1 Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof
08/31/2005EP1567658A2 Intron fusion construct and method of using for selecting high-expressing production cell lines
08/31/2005EP1567646A1 Phosphorylated ndr kinase
08/31/2005EP1567541A2 Rationally designed antibodies
08/31/2005EP1319077B1 Nucleotide sequences which code for the tmk gene
08/31/2005EP1151085B1 Nucleic acid molecules encoding alternansucrase
08/31/2005EP1084250B1 Enzyme
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin
08/31/2005EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
08/31/2005EP0751710B1 Methods and formulations for control of insect pests
08/31/2005CN1662657A Low-cost production of peptides
08/31/2005CN1662656A Flocculation with divalent salt
08/31/2005CN1662654A Preparation of microbial oil containing polyunsaturated fatty acids
08/31/2005CN1662650A Pectate lyase variants
08/31/2005CN1662649A Subtilases and subtilase variants having altered immunogenicity
08/31/2005CN1662642A Pasteurisation process for microbial cells and microbial oil
08/31/2005CN1662281A Method of producing organic material and use of the same
08/31/2005CN1662262A Decoys for treating and/or preventing Th2 cytokine-related allergic diseases, GATA3 mutant proteins and pharmaceutical compositions comprising the decoys and the proteins
08/31/2005CN1662254A ALCAM and ALCAM modulators
08/31/2005CN1662154A Probiotics and oral tolerance
08/31/2005CN1661015A Glutathione synthetase-coding gene of candida utilis
08/31/2005CN1661014A Novel method to isolate mutants and to clone the complementing gene
08/31/2005CN1661008A 3'-Rhodotorula glutinis fungus of 3'-phosphodiester enzyme and method for preparing 3'-nucleotide
08/31/2005CN1661007A New type hypothermal alkaline lipase and marine yeast suitable to cold for producing the lipase
08/31/2005CN1660913A Immunoassays for anti-HCV antibodies
08/31/2005CN1217001C Method of producing D-(-)-3-hydroxy butanoic acid
08/31/2005CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses
08/31/2005CN1216988C Process for producing of secretory kexz derivatives
08/31/2005CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
08/31/2005CN1216901C Method for cleaving chimeric protein using processing enzyme
08/31/2005CN1216890C Cyclipostins, method for their production and use of same
08/30/2005US6936749 Nonsymbiotic plant hemoglobins to maintain cell energy status
08/30/2005US6936707 Modified DNA molecule, recombinant containing the same, and uses thereof
08/30/2005US6936705 nucleic acid sequence that is an insert of a clone selected from the group consisting of: yeast artificial chromosome, isolable from a transformant identified by international deposit number FERM BP-4271; BP-4273; BP-4274
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936699 Filtering through a semipermeable membranes, only low molecular weight with small diameter can pass through
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET)
08/30/2005US6936459 Medium for the production of betacarotene and other carotenoids from dunaliella salina (ARL 5) and a strain of dunaliella salina for production of carotenes using the novel media
08/30/2005US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production
08/30/2005US6936457 DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
08/30/2005US6936456 Bioremediation of nitrogenous contaminants
08/30/2005US6936455 heterologous polypeptide is initially expressed in the form of cytoplasmic inclusion bodies in the host cell, the inclusion bodies are isolated and subsequently treated so that the desired heterologous polypeptide is cleaved autoproteolytically
08/30/2005US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/30/2005US6936447 Autoinducer molecule
08/30/2005US6936446 Sand embedded in polyurethane foams; waste treatment
08/30/2005US6936444 Process for the preparation of L-phosphinothricine by enzymatic transamination with aspartate
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005US6936438 Method of producing a polypeptide using oxaloacetate hydrolase deficient fungal host cells
08/30/2005US6936435 Compositions and methods for regulating bacterial pathogenesis
08/30/2005US6936425 Attenuated salmonella SP12 mutants as antigen carriers
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936259 For therapy and prophylaxis of bacterial infections
08/30/2005US6936250 Polysaccharide encapsualted antigen
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341490C Dna functional group and plasmid coding for hirudine, transformed yeast, preparation process for hirudine, resulting hirudine, and its pharmaceutical use
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/25/2005WO2005078113A1 Method for producing l-threonine using bacteria belonging to the genus escherichia
08/25/2005WO2005078068A1 Live attenuated salmonella for use as vaccine
08/25/2005WO2005078067A1 A culture medium for the production of filamentary fungi
08/25/2005WO2005077148A1 Hyphal culture of sparassis crispa and method of preparing composite culture medium
08/25/2005WO2005076905A2 Culture media compositions free of fetal bovine serum
08/25/2005WO2005063816A3 Monovalent antibody fragments useful as therapeutics
08/25/2005WO2005061716A3 Expression vector used for antibiotic-free expression
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 1489